FR2896690B1 - Utilisation de l'enantiomere(s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique - Google Patents

Utilisation de l'enantiomere(s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique

Info

Publication number
FR2896690B1
FR2896690B1 FR0600811A FR0600811A FR2896690B1 FR 2896690 B1 FR2896690 B1 FR 2896690B1 FR 0600811 A FR0600811 A FR 0600811A FR 0600811 A FR0600811 A FR 0600811A FR 2896690 B1 FR2896690 B1 FR 2896690B1
Authority
FR
France
Prior art keywords
mequitazine
enantiomer
preparation
medicinal product
limiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0600811A
Other languages
English (en)
Other versions
FR2896690A1 (fr
Inventor
Alain Latil
Versailles Jacky Tisne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR0600811A priority Critical patent/FR2896690B1/fr
Priority to PCT/EP2007/050828 priority patent/WO2007085652A1/fr
Publication of FR2896690A1 publication Critical patent/FR2896690A1/fr
Application granted granted Critical
Publication of FR2896690B1 publication Critical patent/FR2896690B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0600811A 2006-01-30 2006-01-30 Utilisation de l'enantiomere(s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique Expired - Fee Related FR2896690B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0600811A FR2896690B1 (fr) 2006-01-30 2006-01-30 Utilisation de l'enantiomere(s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique
PCT/EP2007/050828 WO2007085652A1 (fr) 2006-01-30 2007-01-29 Utilisation de l'enantiomere (s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0600811A FR2896690B1 (fr) 2006-01-30 2006-01-30 Utilisation de l'enantiomere(s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique

Publications (2)

Publication Number Publication Date
FR2896690A1 FR2896690A1 (fr) 2007-08-03
FR2896690B1 true FR2896690B1 (fr) 2008-05-02

Family

ID=37027771

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0600811A Expired - Fee Related FR2896690B1 (fr) 2006-01-30 2006-01-30 Utilisation de l'enantiomere(s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique

Country Status (2)

Country Link
FR (1) FR2896690B1 (fr)
WO (1) WO2007085652A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916142A1 (fr) * 2007-05-15 2008-11-21 Pierre Fabre Medicament Sa Forme pharmaceutique comprenant du (10-[(3s)-1-azabicyclo [2.2.2]oct-3-ylmethyl]-10h-phenothiazine se presentant sous une forme appropriee pour l'administration d'unde dose journaliere comprise entre 1 et 3 mg
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2522660A1 (fr) * 1982-03-05 1983-09-09 Pharmuka Lab Isomere levogyre de la mequitazine, son procede de preparation et medicaments le contenant
FR2772029B1 (fr) * 1997-12-08 2000-02-25 Pf Medicament Procede de preparation de la mequitazine et nouvel intermediaire de synthese

Also Published As

Publication number Publication date
WO2007085652A1 (fr) 2007-08-02
FR2896690A1 (fr) 2007-08-03

Similar Documents

Publication Publication Date Title
BRPI0810646A2 (pt) " compostos farmacêuticos ".
ZA200704163B (en) Oral medicament for the modified release of at least one active principle, in a multimicrocapsule form
TWI366457B (en) Use of a beta2-adrenoceptor agonist for the preparation of a dermatological medicament
IL198301A (en) Aryl amides are stored in thiazole and oxazole, a pharmaceutical preparation containing them and their use in the preparation of drugs
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
FR2959416B1 (fr) Utilisation d'anticorps anti-cd71 pour la preparation d'un medicament
WO2009071690A3 (fr) Dérivés d'oxindole à double substitution en positions 5 et 6 et leur utilisation pour traiter des maladies liées à la vasopressine
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
ECSP066860A (es) Formulaciones de matriz oral que comprenden licarbazepina
FR2898272B1 (fr) Utilisation de derives du 3,5-seco-4-nor-cholestrane pour l'obtention d'un medicament cytoprotecteur
FR2930150B1 (fr) Utilisation de la dronedarone pour la preparation d'un medicament destine a reguler le taux de potassium dans le sang
FR2909879B1 (fr) Utilisation d'un heptapeptide a activite anxiolytique pour la preparation de medicaments et de complements alimentaires
FR2896690B1 (fr) Utilisation de l'enantiomere(s) de la mequitazine pour la preparation d'un medicament, tout en limitant la toxicite genomique
FR2920776B1 (fr) Utilisation de derives de purine pour la fabrication d'un medicament
FR2904318B1 (fr) Derives de pyrimidinone et leur utilisation comme medicament
FR2924019B1 (fr) Dispositif de preparation d'un produit pharmaceutique ou medicamenteux injectable
ZA201005398B (en) 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative,use thereof,and medicament containing said derivative
FR2924345B1 (fr) Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
FR2907784B1 (fr) Derives phenyliques et leur utilisation comme medicament
FR2878160B1 (fr) Utilisation du n-acetyl-taurinate de magnesium pour la preparation de medicaments inhibiteurs de l'hypersensiblite photique
FR2946534B1 (fr) Utilisation d'alkylglycerols pour la preparation de medicaments.
UA10726S (uk) Комплект упаковок для фармацевтичного препарату «дермазол»
UA9011S (uk) Упаковка фармацевтичного засобу «кетозорал»
UA10680S (uk) Упаковка фармацевтичного засобу «корвалол-новий-дарниця»
UA11241S (uk) Упаковка для фармацевтичного препарату «кофол»

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150930